Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Intermittent Selumetinib for Uveal Melanoma

NCT02768766

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • Columbia University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

NCT03245151

Conditions
Central Nervous System Neoplasms, Disease Attributes, Glioma, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Miller Children's and Women's Hospital Long Beach, California, United States
View all 50 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

NCT02658890

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Local Institution - 0028 Tucson, Arizona, United States
  • Local Institution - 0026 La Jolla, California, United States
  • Local Institution - 0035 Tampa, Florida, United States
  • Local Institution - 0005 Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Completed

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

NCT01152788

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View all 19 locations
View Trial Details
Completed

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00482677

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View all 22 locations
View Trial Details
Completed

A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

NCT01259869

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions